Positive association between anti-Helicobacter pylori IgG antibody titers and atrophic gastritis in a Latvian cohort
Gastric Cancer · 2025
DOI: 10.1007/s10120-025-01629-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastric Cancer, 2025. Verfasst von Joo Hyun Lim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Gastritis, Atrophic, Helicobacter pylori, Helicobacter Infections, Immunoglobulin G. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: World Health Organization, European Regional Development Fund.
Abstract (Originalsprache)
BACKGROUND: Although H. pylori is the most important risk factor for gastric cancer, the role of anti-H. pylori antibody titers in gastric carcinogenesis has not been investigated outside Asia. We aimed to analyze the relationship between H. pylori antibody titers and the risk of gastric precancerous lesions in a Caucasian population. METHODS: We analyzed the GISTAR pilot study data on participants from Latvia with available anti-H. pylori IgG antibody serology and histopathological information. Participants were classified into four groups according to antibody titer: low-negative (LN), high-negative (HN), low-positive (LP), and high-positive (HP). Odds ratios (ORs) for atrophic gastritis among the 4 groups were compared using logistic regression. RESULTS: Among a total of 1725 individuals, 970 with available histopathological information were included. A total of 738 individuals (76.1%) had histologically diagnosed atrophic gastritis. Risk of histological atrophic gastritis for each group compared to LN was as follows: HN (OR, 1.52; 95% confidence interval (CI) 0.85-2.72), LP (OR 2.04; 95% CI 1.25-3.32), and HP (OR, 2.47; 95% CI 1.50-4.07). Antibody titer as a continuous variable showed a positive relationship with histological atrophic gastritis (OR 1.09 per 10 EIU; 95% CI 1.04-1.14). The positive relationship was clearer among those aged ≥ 50 years. CONCLUSIONS: Anti-H. pylori antibody titer was positively related to the risk of atrophic gastritis in a middle-aged Caucasian population, suggesting its potential complementary role in gastric cancer risk stratification in a European setting where upper endoscopic examination is less routinely available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, South Korea.
- Early Detection, Prevention and Infections Branch, International Agency for Research On Cancer (IARC/WHO), 25 Avenue Tony Garnier, 69007, Lyon, France.
- Faculty of Medicine and Lifesciences, Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
- Digestive Diseases Centre GASTRO, Riga, Latvia.
- Academic Histology Laboratory, Riga, Latvia.
ORCID-Profile: Mārcis Leja, Jin Young Park
Förderung
- World Health Organization
- European Regional Development Fund
Zitieren
APA
Lim, J. H., Poļaka, I., Ražuka-Ebela, D., Bogdanova, I., Parshutin, S., Leja, M., & Park, J. Y. (2025). Positive association between anti-Helicobacter pylori IgG antibody titers and atrophic gastritis in a Latvian cohort. Gastric Cancer. https://doi.org/10.1007/s10120-025-01629-3
Vancouver
Lim JH, Poļaka I, Ražuka-Ebela D, Bogdanova I, Parshutin S, Leja M, et al. Positive association between anti-Helicobacter pylori IgG antibody titers and atrophic gastritis in a Latvian cohort. Gastric Cancer. 2025. doi:10.1007/s10120-025-01629-3
BibTeX
@article{Lim2025,
author = {Lim, Joo Hyun and Poļaka, Inese and Ražuka-Ebela, Danute and Bogdanova, Inga and Parshutin, Sergei and Leja, Mārcis and Park, Jin Young},
title = {Positive association between anti-Helicobacter pylori IgG antibody titers and atrophic gastritis in a Latvian cohort},
journal = {Gastric Cancer},
year = {2025},
doi = {10.1007/s10120-025-01629-3}
}
EUVIMED